Patents by Inventor Robert A. Newman

Robert A. Newman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10383886
    Abstract: A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside, and optionally triterpene(s), to a subject. The cardiac glycoside can be present in a dosage form.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: August 20, 2019
    Assignee: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Otis C. Addington, Robert A. Newman
  • Publication number: 20190240277
    Abstract: A method of treating neurological condition in a subject by administration of a neuroprotective composition of a mixture of two or more triterpenes. Alzheimer's disease, Huntington's disease, stroke or Parkinson's disease are treated by administering a therapeutically effective amount of the neuroprotective composition to a subject.
    Type: Application
    Filed: April 17, 2019
    Publication date: August 8, 2019
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: OTIS C. ADDINGTON, ROBERT A. NEWMAN
  • Publication number: 20190175634
    Abstract: A method of treating viral infection, such as viral infection caused by a virus of the Filoviridae, Flaviviridae or Togaviriade family, is provided. A composition having at least one cardiac glycoside is used to treat viral infection. The composition can further include at least one triterpene.
    Type: Application
    Filed: February 14, 2019
    Publication date: June 13, 2019
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Robert A. NEWMAN, Otis C. ADDINGTON
  • Patent number: 10309308
    Abstract: A gas turbine engine includes a mid-turbine frame that includes an inner frame case. At least one spoke is connected to the inner frame case. At least one spoke includes a fluid passage that is in fluid communication with a channel on a radially inner end of the fluid passage. The channel is directed in a radially inward and circumferential direction. A cavity is located radially inward from the mid-turbine frame and is in fluid communication with the channel.
    Type: Grant
    Filed: January 16, 2015
    Date of Patent: June 4, 2019
    Assignee: UNITED TECHNOLOGIES CORPORATION
    Inventors: Anthony P. Cherolis, Jeffrey J. Lienau, Robert Newman, Cheng-Zhang Wang
  • Patent number: 10307450
    Abstract: A method of treating neurological condition in a subject by administration of a neuroprotective composition of a mixture of two or more triterpenes. Alzheimer's disease, Huntington's disease, stroke or Parkinson's disease are treated by administering a therapeutically effective amount of the neuroprotective composition to a subject.
    Type: Grant
    Filed: September 14, 2017
    Date of Patent: June 4, 2019
    Assignee: Phoenix Biotechnology, Inc.
    Inventors: Otis C. Addington, Robert A. Newman
  • Patent number: 10241015
    Abstract: A method and a cryogenic sample positioning system are provided which include: a sample holder cassette that is vertically coupled to a carousel gear through a first shaft. Each sample holder cassette has a first degree of rotation about the first shaft. A first planet drive gear underlies and is vertically coupled to the carousel gear through a second shaft that extends from the carousel gear through the first planet drive gear. The carousel gear has a second degree of rotation about the second shaft that is different from the first degree of rotation. A planet gear that is laterally connected to a second planet drive gear is interposed between each of the carousel gear and the first planet drive gear. Each of the planet gear and the second planet drive gear selectively define the first degree of rotation, without affecting the second degree of rotation of the carousel gear.
    Type: Grant
    Filed: July 24, 2017
    Date of Patent: March 26, 2019
    Assignee: Mitegen, LLC
    Inventors: Stephen Hollabaugh, Robert Newman, David Closs
  • Publication number: 20190076381
    Abstract: A method of treating a triterpene-responsive condition, disease or disorder in a subject by administration of an improved triterpene-based composition is provided. An improved triterpene-based composition comprising at least two or at least three triterpenes present at a molar ratio as described herein is also provided.
    Type: Application
    Filed: November 8, 2018
    Publication date: March 14, 2019
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: ROBERT A. NEWMAN, OTIS C. ADDINGTON, DONALD C. LO, LINDA S. KALTENBACH
  • Patent number: 10226497
    Abstract: A method of treating neurological condition in a subject by administration of a pharmaceutical composition that excludes cardiac glycoside and excludes polysaccharide obtained from Nerium species or Thevetia species. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of the pharmaceutical composition to a subject.
    Type: Grant
    Filed: June 8, 2017
    Date of Patent: March 12, 2019
    Assignee: Phoenix Biotechnology, Inc.
    Inventors: Otis C. Addington, Robert A. Newman
  • Publication number: 20190046623
    Abstract: The invention features multi-specific fusion protein complexes with one domain comprising IL-15 or a functional variant and a binding domain specific to IL-12 or IL-18.
    Type: Application
    Filed: March 6, 2018
    Publication date: February 14, 2019
    Inventors: Warren D. Marcus, Robert Newman, Bai Liu, Lijing You, Lin Kong, Peter Rhode, Hing C. Wong
  • Patent number: 10087782
    Abstract: A turbine engine includes a turbine section with a low pressure turbine and a turbine case disposed about an axis. A frame assembly defines an outer cavity and an inner cavity with the outer cavity including at least one opening configured and adapted to communicate cooling air to the turbine case. A transfer tube is disposed within the outer cavity and is configured and adapted to receive cooling air. The transfer tube includes a bend configured to impart circumferential velocity to the cooling air within the outer cavity.
    Type: Grant
    Filed: March 12, 2014
    Date of Patent: October 2, 2018
    Assignee: United Technologies Corporation
    Inventors: Cheng-Zhang Wang, Jorn A. Glahn, David F. Cloud, Peter M. Munsell, Clifton J. Crawley, Jr., Robert Newman, Michelle Diana Stearns
  • Publication number: 20180096325
    Abstract: A system for converting physical coins into digital currency at a point of sale during a cash transaction at a retailer and related methods. A mobile app residing on a customer's mobile device communicates with a control module to manage the customer's account and obtain an identifier associated with the customer's account. During a cash transaction where physical change is due, the mobile device transmits the identifier to the point of sale. The point of sale transmits the identifier and the amount of change due to the control module. The control module confirms the identity of the customer using the identifier and directs a financial institution to move the amount of change due from the retailer's bank account to one or more designated bank accounts, one of which may be the customer's bank account.
    Type: Application
    Filed: October 4, 2016
    Publication date: April 5, 2018
    Applicant: NUMIS TECHNOLOGIES, LLC
    Inventors: Matthew Panzo, Steve Shamrock, Christian Thomas Chicles, Lydia Chicles, David Michael Booth, David Robert Newman
  • Publication number: 20180042976
    Abstract: A method of treating neurological condition in a subject by administration of a neuroprotective composition of a mixture of two or more triterpenes. Alzheimer's disease, Huntington's disease, stroke or Parkinson's disease are treated by administering a therapeutically effective amount of the neuroprotective composition to a subject.
    Type: Application
    Filed: September 14, 2017
    Publication date: February 15, 2018
    Applicant: Phoenix Biotechnology, Inc.
    Inventors: Otis C. ADDINGTON, Robert A. NEWMAN
  • Patent number: 9877979
    Abstract: A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside to a subject. The cardiac glycoside can be present in a dosage form.
    Type: Grant
    Filed: May 2, 2016
    Date of Patent: January 30, 2018
    Assignee: Phoenix Biotechnology, Inc.
    Inventors: Otis C. Addington, Robert A. Newman
  • Publication number: 20180024032
    Abstract: A method and a cryogenic sample positioning system are provided which include: a sample holder cassette that is vertically coupled to a carousel gear through a first shaft. Each sample holder cassette has a first degree of rotation about the first shaft. A first planet drive gear underlies and is vertically coupled to the carousel gear through a second shaft that extends from the carousel gear through the first planet drive gear. The carousel gear has a second degree of rotation about the second shaft that is different from the first degree of rotation. A planet gear that is laterally connected to a second planet drive gear is interposed between each of the carousel gear and the first planet drive gear. Each of the planet gear and the second planet drive gear selectively define the first degree of rotation, without affecting the second degree of rotation of the carousel gear.
    Type: Application
    Filed: July 24, 2017
    Publication date: January 25, 2018
    Applicant: Mitegen, LLC
    Inventors: Stephen Hollabaugh, Robert Newman, David Closs
  • Publication number: 20180000852
    Abstract: A method of treating neurological condition in a subject by administration of a cardiac glycoside is provided. Alzheimer's disease, Huntington's disease or stroke are treated by administering a therapeutically effective amount of cardiac glycoside, and optionally triterpene(s), to a subject. The cardiac glycoside can be present in a dosage form.
    Type: Application
    Filed: September 14, 2017
    Publication date: January 4, 2018
    Applicant: PHOENIX BIOTECHNOLOGY, INC.
    Inventors: Otis C. ADDINGTON, Robert A. NEWMAN
  • Patent number: 9855557
    Abstract: Devices and methods for manual and high-throughput protein crystal growth and growth of other biological and organic crystals. A microplate includes a plurality of cells and a frame that defines the cells in the microplate. In each cell there is at least one well open at top. Each well in a cell may be enclosed at bottom, or it may be open at bottom, in which case the well bottom may be sealed by a separate part, which may be, e.g., a separate film or plate (e.g., of plastic, glass or metal) or a molded part.
    Type: Grant
    Filed: March 28, 2013
    Date of Patent: January 2, 2018
    Assignee: MITEGEN, LLC
    Inventors: Robert E. Thorne, Benjamin Apker, Robert Newman
  • Patent number: 9846156
    Abstract: A method of treatment employing cardiac glycoside is disclosed. A prognostic assay and kit and method of use thereof are provided. The kit and assay are used to determine the likelihood of a diseased cell or tissue having a therapeutic response to treatment with a cardiac glycoside in a disease having an etiology associated with excessive cell proliferation. The kit and assay are used to determine the ratio of isoforms of the ? subunit of Na, K-ATPase obtained from the diseased cell or tissue. The kit can be used to predict the therapeutic responsiveness of cancer or tumor in a subject to treatment with a cardiac glycoside. The kit and assay can be incorporated in a method of treating a disease or disorder having an etiology associated with excessive cell proliferation with a composition comprising a cardiac glycoside.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: December 19, 2017
    Inventors: Otis C. Addington, Peiying Yang, Robert A. Newman
  • Patent number: 9808495
    Abstract: The present subject matter relates to a novel herbal and oil composition and methods for modulating fatty acid composition and metabolism in an animal. In one aspect, the subject matter involves a composition comprising rosemary extract, oregano extract, and a polyunsaturated oil. In a particular embodiment, the polyunsaturated oil is fish oil or a derivative thereof. In some embodiments, the present subject matter relates to methods for modulating essential dietary fatty acid composition of lipoprotein particles or cell membranes, modulating essential fatty acid metabolism, regulating the activity of lipoxygenases and cyclooxygenases, improving cardiovascular health, and/or inhibiting cell proliferation diseases and disorders.
    Type: Grant
    Filed: May 28, 2010
    Date of Patent: November 7, 2017
    Assignee: The Procter & Gamble Company
    Inventors: Robert A. Newman, Peiying Yang, Paul Schulick
  • Patent number: 9803502
    Abstract: A mid-turbine frame assembly includes an inner frame case which includes a first plurality of holes and a second plurality of holes. A plurality of tie rods is circumferentially spaced around the inner frame case and includes an inlet passage that is aligned with the first plurality of holes. A plurality of hollow airfoils is aligned with the second plurality of holes.
    Type: Grant
    Filed: February 9, 2015
    Date of Patent: October 31, 2017
    Assignee: UNITED TECHNOLOGIES CORPORATION
    Inventors: Anthony P. Cherolis, Jeffrey J. Lienau, Robert Newman, John H. Mosley, Joshua Daniel Winn, Paul K. Sanchez
  • Patent number: 9795647
    Abstract: This disclosure relates to novel herbal compositions comprising extracts of rosemary and oregano, and methods of using the herbal compositions to modulate inflammatory potential. One or both of the extracts may be supercritical extracts. The disclosure further relates to methods of treating inflammation, rheumatoid arthritis, osteoarthritis, or combinations thereof, using the herbal compositions.
    Type: Grant
    Filed: September 12, 2014
    Date of Patent: October 24, 2017
    Assignee: The Procter & Gamble Company
    Inventors: Robert A. Newman, Peiying Yang, Paul Schulick